· Updated · Venture Capital Tracker · investment-strategies · 3 min read
NYC's Top 15 VC Firms in 2026: Ranked by AUM, Stage, and Track Record
NYC's startup investment leaders in 2026 — Insight (~$90B), Thrive (~$50B+ reported), Primary ($625M Fund V), and peers — by AUM, stage, typical check, and who founders should pitch.
Short answer (as of August 2026): NYC’s startup investment leaders stack three layers — growth-scale capital (Insight Partners ~$90B), multi-stage crossover (Thrive Capital ~$50B+ reported), and seed leads (Primary Venture Partners $625M Fund V, Lerer Hippeau, BoxGroup). This page ranks by approximate AUM; for seed-mandate and deal activity, use the linked rankings below. AUM figures are industry approximations — not audited filings.
Related maps: Seed ranking 2026 · Most active 2024–2026 · Series A shortlist · East Coast hub · Directory
The ranking (by AUM, approximate)
| Rank | Firm | AUM (approx) | Stage focus | Typical check (indicative) | 2025–26 notable deal / event | Best for founders when… | Profile |
|---|---|---|---|---|---|---|---|
| 1 | Insight Partners | ~$90B | Growth-stage software | $25M–$500M+ (ScaleUp) | Wiz → Google ~$32B (2025); ongoing software exits | ~$10M+ ARR software; want ops support | /fund/insight-partners |
| 2 | General Atlantic | ~$80B+ (PE+growth) | Growth equity | $50M–$500M+ | Global growth portfolio (no single NYC headline deal) | Late growth / PE-adjacent scaling | — |
| 3 | Thrive Capital | ~$50B+ (reported) | Multi-stage / crossover | $5M–$500M+ (concentrated) | Isomorphic Labs $600M (Mar 2025); $2.1B Series B led (May 2026) | Category-defining internet/AI | /fund/thrive-capital |
| 4 | Tiger Global | ~$60B (global) | Crossover / late-stage | $10M–$200M+ | Global crossover book; NYC presence | Late-stage / crossover dynamics | /fund/tiger-global-management |
| 5 | Lux Capital | ~$4B+ | Deep tech / frontier | $5M–$50M | Flourish $500M round co-back (Jun 2026) | Science, deep tech, frontier systems | /fund/lux-capital |
| 6 | Union Square Ventures (USV) | ~$2.5B+ | Early / thesis-driven | $1M–$15M | Thesis-driven early bets (networks, climate, fintech) | Thesis fit over sector spray | /fund/union-square-ventures |
| 7 | RRE Ventures | ~$2.5B | Early–growth | $2M–$30M | Multi-stage NYC generalist history | Multi-stage NYC generalist | /fund/rre-ventures |
| 8 | Greycroft | ~$1B+ | Consumer, fintech, media | $1M–$25M | Jesse & Ben’s, Recursive Series A leads (May 2026) | Seed through growth, NY + LA | /fund/greycroft |
| 9 | Nyca Partners | ~$1B | Fintech | $2M–$20M | Fintech specialist mandate | Fintech-only thesis | — |
| 10 | FirstMark Capital | ~$1B | Early enterprise/consumer | $1M–$15M | Early NYC generalist | Early enterprise/consumer | — |
| 11 | Lerer Hippeau | ~$750M+ | Seed (consumer/SaaS) | $500K–$5M | High-volume NYC seed leads | First institutional seed | /fund/lerer-hippeau |
| 12 | Primary Venture Partners | $625M Fund V | Seed (NYC-rooted) | $1M–$5M | $625M Fund V close (Feb 2026) | Institutional NYC seed lead | /fund/primary-venture-partners |
| 13 | BoxGroup | — | Ultra-early | $250K–$2M | AlleyWatch Q2 2026 most-active NYC investor (9 deals) | First-check / company formation | /fund/box-group |
| 14 | Work-Bench | — | Enterprise B2B seed | $500K–$3M | Enterprise-only seed + GTM network | B2B seed with enterprise buyers | /fund/work-bench |
| 15 | BBG Ventures | — | Consumer, women-led | $250K–$1.5M | Consumer / women-led early mandate | Consumer, women-led early | — |
Typical checks are indicative industry ranges — not firm-published guarantees. Notable deals sourced from public announcements and our most-active investors coverage.
AUM vs activity: AUM answers “who has balance-sheet gravity.” It does not answer “who leads my seed.” Use seed ranking and most-active investors for that job. Track-record proxies (exits/unicorns, not invented DPI): NYC VC track record 2026.
Notable 2025–2026 activity
- Primary Venture Partners: Closed $625M Fund V (Feb 2026) — largest dedicated NYC-rooted seed vehicle in recent coverage. Playbook: Primary Fund V.
- Thrive Capital: Led Isomorphic Labs’ $600M external round (Mar 2025) and $2.1B Series B (May 2026); ongoing OpenAI exposure. Diligence: How to evaluate Thrive.
- Insight Partners: Growth software + ScaleUp playbook; Wiz exit (Google ~$32B, 2025). Check bands: Insight SaaS check size & exits.
- BoxGroup: Highest Q2 2026 deal count on AlleyWatch NYC index (9 visible deals).
What NYC firms do differently
- Fewer hype rounds: NYC VCs are generally more valuation-disciplined than Bay Area peers on applied verticals.
- Vertical SaaS specialization: Fintech, enterprise, health, and applied AI show up repeatedly (Ramp, billing agents, clinical AI).
- Operator networks: Many GPs are former founders (Lerer, Hippeau, BoxGroup pattern).
- Global reach from NYC HQ: Thrive, Insight, Tiger, General Atlantic run global portfolios without relocating founders to SF.
How founders should use this list
- Match stage: Insight won’t write seed; BoxGroup won’t lead Series C.
- Match sector: Nyca for fintech, Work-Bench for enterprise, Lux for deep tech.
- Ask partner, not firm: Partner quality and lead behavior beat logo.
- Next shortlists: Series A NYC · Seed → IPO multi-stage · East Coast.
Sources
- Ellenox NYC VC rankings: https://www.ellenox.com/post/new-york-city-venture-capital-firms
- Private Equity List top VCs: https://privateequitylist.com/resources/top-venture-capital-firms
- VCSheet NYC-focused funds: https://www.vcsheet.com/sheet/nyc-focused-funds
- Visible.vc NYC VCs: https://visible.vc/blog/venture-capital-firms-in-nyc/
- Isomorphic Labs Series B (May 12, 2026): https://www.isomorphiclabs.com/articles/isomorphic-labs-announces-series-b-investment-round
- Primary Fund V (Feb 2026): https://techcrunch.com/2026/02/10/primary-ventures-raises-massive-625m-fund-v-to-focus-on-seed-investing
- AlleyWatch Q2 2026 NYC funding: https://alleywatch.com/2026/07/nyc-startup-funding-q2-2026-best-capital-quarter-since-2021/
- vc-explainers
- nyc-startups
- venture-capital
- +1 more
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.